Nature,
Journal Year:
2024,
Volume and Issue:
630(8016), P. 447 - 456
Published: June 5, 2024
Abstract
Increasing
rates
of
autoimmune
and
inflammatory
disease
present
a
burgeoning
threat
to
human
health
1
.
This
is
compounded
by
the
limited
efficacy
available
treatments
high
failure
during
drug
development
2
,
highlighting
an
urgent
need
better
understand
mechanisms.
Here
we
show
how
functional
genomics
could
address
this
challenge.
By
investigating
intergenic
haplotype
on
chr21q22—which
has
been
independently
linked
bowel
disease,
ankylosing
spondylitis,
primary
sclerosing
cholangitis
Takayasu’s
arteritis
3–6
—we
identify
that
causal
gene,
ETS2
central
regulator
macrophages
delineate
shared
mechanism
amplifies
expression.
Genes
regulated
were
prominently
expressed
in
diseased
tissues
more
enriched
for
GWAS
hits
than
most
previously
described
pathways.
Overexpressing
resting
reproduced
state
observed
chr21q22-associated
diseases,
with
upregulation
multiple
targets,
including
TNF
IL-23.
Using
database
cellular
signatures
7
identified
drugs
might
modulate
pathway
validated
potent
anti-inflammatory
activity
one
class
small
molecules
vitro
ex
vivo.
Together,
illustrates
power
genomics,
applied
directly
cells,
immune-mediated
mechanisms
potential
therapeutic
opportunities.
Nature,
Journal Year:
2023,
Volume and Issue:
613(7944), P. 508 - 518
Published: Jan. 18, 2023
Abstract
Population
isolates
such
as
those
in
Finland
benefit
genetic
research
because
deleterious
alleles
are
often
concentrated
on
a
small
number
of
low-frequency
variants
(0.1%
≤
minor
allele
frequency
<
5%).
These
survived
the
founding
bottleneck
rather
than
being
distributed
over
large
ultrarare
variants.
Although
this
effect
is
well
established
Mendelian
genetics,
its
value
common
disease
genetics
less
explored
1,2
.
FinnGen
aims
to
study
genome
and
national
health
register
data
500,000
Finnish
individuals.
Given
relatively
high
median
age
participants
(63
years)
substantial
fraction
hospital-based
recruitment,
enriched
for
end
points.
Here
we
analyse
from
224,737
15
diseases
that
have
previously
been
investigated
genome-wide
association
studies
(GWASs).
We
also
include
meta-analyses
biobank
Estonia
United
Kingdom.
identified
30
new
associations,
primarily
variants,
population.
A
GWAS
1,932
2,733
significant
associations
(893
phenome-wide
(PWS),
P
2.6
×
10
–11
)
at
2,496
(771
PWS)
independent
loci
with
807
(247
Among
these,
fine-mapping
implicated
148
(73
coding
associated
83
(42
Moreover,
91
(47
had
an
<5%
non-Finnish
European
individuals,
which
62
(32
were
by
more
twofold
Finland.
findings
demonstrate
power
bottlenecked
populations
find
entry
points
into
biology
through
low-frequency,
impact
Nucleic Acids Research,
Journal Year:
2021,
Volume and Issue:
50(D1), P. D988 - D995
Published: Oct. 19, 2021
Ensembl
(https://www.ensembl.org)
is
unique
in
its
flexible
infrastructure
for
access
to
genomic
data
and
annotation.
It
has
been
designed
efficiently
deliver
annotation
at
scale
all
eukaryotic
life,
it
also
provides
deep
comprehensive
key
species.
Genomes
representing
a
greater
diversity
of
species
are
increasingly
being
sequenced.
In
response,
we
have
focussed
our
recent
efforts
on
expediting
the
new
assemblies.
Here,
report
release
greatest
annual
number
newly
annotated
genomes
history
via
dedicated
Rapid
Release
platform
(http://rapid.ensembl.org).
We
developed
method
generate
comparative
analyses
these
assemblies
and,
first
time,
non-vertebrate
eukaryotes.
Meanwhile,
continually
improve,
extend
update
high-value
reference
vertebrate
details
here.
range
specific
software
tools
tasks,
such
as
Variant
Effect
Predictor
(VEP)
interface
Recoder.
All
data,
freely
available
download
accessible
programmatically.
Nucleic Acids Research,
Journal Year:
2020,
Volume and Issue:
49(D1), P. D1311 - D1320
Published: Sept. 17, 2020
Open
Targets
Genetics
(https://genetics.opentargets.org)
is
an
open-access
integrative
resource
that
aggregates
human
GWAS
and
functional
genomics
data
including
gene
expression,
protein
abundance,
chromatin
interaction
conformation
from
a
wide
range
of
cell
types
tissues
to
make
robust
connections
between
GWAS-associated
loci,
variants
likely
causal
genes.
This
enables
systematic
identification
prioritisation
genes
across
all
published
trait-associated
loci.
In
this
paper,
we
describe
the
public
resources
aggregate,
technology
analyses
use,
functionality
portal
offers.
can
be
searched
by
variant,
or
study/phenotype.
It
offers
tools
enable
users
prioritise
at
disease-associated
loci
access
cross-disease
disease-molecular
trait
colocalization
analysis
92
eQTL
Catalogue.
Data
visualizations
such
as
Manhattan-like
plots,
regional
credible
sets
overlap
studies
PheWAS
plots
explore
signals
in
depth.
The
integrated
made
available
through
web
portal,
for
bulk
download
via
GraphQL
API,
software
open
source.
Applications
include
novel
targets
drug
discovery
repurposing.
Nature Immunology,
Journal Year:
2023,
Volume and Issue:
24(9), P. 1540 - 1551
Published: Aug. 10, 2023
Circulating
proteins
have
important
functions
in
inflammation
and
a
broad
range
of
diseases.
To
identify
genetic
influences
on
inflammation-related
proteins,
we
conducted
genome-wide
protein
quantitative
trait
locus
(pQTL)
study
91
plasma
measured
using
the
Olink
Target
platform
14,824
participants.
We
identified
180
pQTLs
(59
cis,
121
trans).
Integration
pQTL
data
with
eQTL
disease
association
studies
provided
insight
into
pathogenesis,
implicating
lymphotoxin-α
multiple
sclerosis.
Using
Mendelian
randomization
(MR)
to
assess
causality
etiology,
both
shared
distinct
effects
specific
across
immune-mediated
diseases,
including
directionally
discordant
CD40
risk
rheumatoid
arthritis
versus
sclerosis
inflammatory
bowel
disease.
MR
implicated
CXCL5
etiology
ulcerative
colitis
(UC)
show
elevated
gut
transcript
expression
patients
UC.
These
results
targets
existing
drugs
provide
powerful
resource
facilitate
future
drug
target
prioritization.
medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2022,
Volume and Issue:
unknown
Published: March 6, 2022
ABSTRACT
Population
isolates
such
as
Finland
provide
benefits
in
genetic
studies
because
the
allelic
spectrum
of
damaging
alleles
any
gene
is
often
concentrated
on
a
small
number
low-frequency
variants
(0.1%
≤
minor
allele
frequency
<
5%),
which
survived
founding
bottleneck,
opposed
to
being
distributed
over
much
larger
ultra--rare
variants.
While
this
advantage
well--
established
Mendelian
genetics,
its
value
common
disease
genetics
has
been
less
explored.
FinnGen
aims
study
genome
and
national
health
register
data
500,000
Finns,
already
reaching
224,737
genotyped
phenotyped
participants.
Given
relatively
high
median
age
participants
(63
years)
dominance
hospital-based
recruitment,
enriched
for
many
endpoints
underrepresented
population-based
(e.g.,
rarer
immune-mediated
diseases
late
onset
degenerative
ophthalmologic
endpoints).
We
report
here
genome-wide
association
(GWAS)
1,932
clinical
defined
from
nationwide
registries.
identify
genome--wide
significant
associations
at
2,491
independent
loci.
Among
these,
finemapping
implicates
148
putatively
causal
coding
associated
with
202
endpoints,
104
low
(AF<10%)
62
were
two-fold
Finland.
studied
benchmark
set
15
that
had
previously
investigated
large
studies.
discovery
analyses
meta-analysed
Estonian
UK
biobanks.
30
novel
associations,
primarily
strongly
enriched,
or
specific
to,
Finnish
population
Uralic
language
family
neighbors
Estonia
Russia.
These
findings
demonstrate
power
bottlenecked
populations
find
unique
entry
points
into
biology
through
low-frequency,
impact
Such
have
potential
contribute
medical
translation
including
drug
discovery.
Nature Genetics,
Journal Year:
2022,
Volume and Issue:
54(2), P. 152 - 160
Published: Feb. 1, 2022
Migraine
affects
over
a
billion
individuals
worldwide
but
its
genetic
underpinning
remains
largely
unknown.
Here,
we
performed
genome-wide
association
study
of
102,084
migraine
cases
and
771,257
controls
identified
123
loci,
which
86
are
previously
These
loci
provide
an
opportunity
to
evaluate
shared
distinct
components
in
the
two
main
subtypes:
with
aura
without
aura.
Stratification
risk
using
29,679
subtype
information
indicated
three
variants
that
seem
specific
for
(in
HMOX2,
CACNA1A
MPPED2),
(near
SPINK2
near
FECH)
nine
increase
susceptibility
regardless
subtype.
The
new
include
genes
encoding
recent
migraine-specific
drug
targets,
namely
calcitonin
gene-related
peptide
(CALCA/CALCB)
serotonin
1F
receptor
(HTR1F).
Overall,
genomic
annotations
among
migraine-associated
were
enriched
both
vascular
central
nervous
system
tissue/cell
types,
supporting
unequivocally
neurovascular
mechanisms
underlie
pathophysiology.